Companies / Johnson & Johnson
Johnson & Johnson
Financials · FY2025
Ownership
2.41B shares outstanding · as of Jul 17, 2026
Ownership
| Insiders | 0.03% | 844,266 |
| 10%+ / strategic | 10.10% | 243,455,135 |
| Institutions | 63.93% | 1,540,716,679 |
| Public float | 25.93% | 624,882,517 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 16
View all →| Insider | % of shares | Shares |
|---|---|---|
Duato JoaquinCEOCEO and Chairman of the Board · Director | 0.01% | 355,299 |
Taubert Jennifer LEVP, WWC. Innovative Medicine | <0.01% | 194,451 |
Wengel Kathryn EEVP, Chief TO and Risk Officer | <0.01% | 114,288 |
Swanson James D.EVP, CIO | <0.01% | 25,698 |
Schmid TimothyEVP, WW Chair, MedTech | <0.01% | 25,447 |
Reed John CEVP, Innovative Medicine, R&D | <0.01% | 24,911 |
Decker Robert JVP Corporate Controller | <0.01% | 23,682 |
Forminard ElizabethEVP, Chief Legal Officer | <0.01% | 23,568 |
Broadhurst VanessaEVP, Global Corp Affairs | <0.01% | 23,003 |
Mulholland KristenEVP, Chief HR Officer | <0.01% | 19,830 |
Institutional holders 4,501
View all →| Holder | Value | % of shares |
|---|---|---|
| $53.87B | 8.80% | |
| $49.74B | 9.97% | |
| $33.98B | 5.55% | |
| $14.42B | 2.46% | |
| $12.12B | 2.43% | |
| $9.59B | 1.92% | |
| $6.92B | 1.39% | |
| $6.54B | 1.31% | |
| $6.06B | 1.22% | |
| $5.86B | 1.18% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Norges Bank 13F manager | Exit | — | $-6.92B | -33.5M -100.00% | — | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $842.45M | +3.3M +1.59% | 212,098,264 8.80% of shares | high |
| Q1 2026 as of | TD Asset Management Inc 13F manager | Add | — | $735.02M | +3.0M +192.93% | 4,565,498 0.19% of shares | high |
| Q1 2026 as of | Voya Investment Management LLC 13F manager | Add | — | $678.46M | +2.8M +308.02% | 3,677,872 0.15% of shares | high |
| Q2 2023 as of | Barclays PLC 13F manager | Add | — | $671.86M | +4.1M +56.15% | 11,287,765 0.47% of shares | high |
| Q1 2026 as of | Bank of New York Mellon Corp/The 13F manager | Trim | — | $-628.78M | -2.6M -10.54% | 21,821,962 0.91% of shares | high |
| Q3 2025 as of | Broadwater Capital Management LLC 13F manager | Trim | — | $-621.93M | -3.4M -99.35% | 22,043 <0.01% of shares | high |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | — | $-619.26M | -4.0M -35.60% | 7,228,653 0.30% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| JNJ | — | 478160104 |